SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FibroGen, Inc. and Astellas Pharma Inc. Announce Initiation of Phase 3 Trial of FG-4592/ASP1517 for Treatment of Anemia of Chronic Kidney Disease
Your Message